Fanconi anemia (FA) is the most common inherited bone marrow failure syndrome, characterized by cellular DNA repair deficiency, developmental defects, and a 700-fold increased risk of developing ...

On track to provide clinical data from the 12 mg dose cohort from the Phase 1b PIONEER trial of pociredir in SCD in mid-2025 and the 20 mg dose cohort by the end of 2025 ― ― Ended 2024 with $241.0 ...

On track to provide clinical data from the 12 mg dose cohort from the Phase 1b PIONEER trial of pociredir in SCD in mid-2025 ...

For the past month, local basketball programs have teamed up to raise awareness and spread hope for 9-year-old Autumn and ...

Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...

First Stem Cell and Genomics Laboratory (FSG), formerly known before as Hortman Stem Cell Laboratory and with the support of the Dubai Health Authority, is organising the third Dubai Stem Cell ...

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) is anticipated to issue its quarterly earnings data before the market ...

Strategic Financial Concepts LLC acquired a new stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) during the ...